Pacemaker lead-associated thrombosis in cardiac resynchronisation therapyBMJ Case Reports - - Trang bcr2015210314
Jesmar Buttigieg, Rachelle Asciak, Charles Mallia Azzopardi
Pacemaker lead-associated thrombosis is a possible complication of any cardiac
implantable electronic device. We present a case of a middle-aged woman with a
history of ischaemic left ventricular failure, who presented with fever and
other non-specific symptoms 4 months after cardiac resynchronisation therapy. A
transoesophageal echocardiogram confirmed a vegetation-like structure
originating from... hiện toàn bộ
Guillain-Barré syndrome associated with COVID-19 infection: a case from the UKBMJ Case Reports - Tập 13 Số 7 - Trang e236536 - 2020
May Yung Tiet, Nazar AlShaikh
Originating from Wuhan, China, COVID-19 has rapidly spread worldwide.
Neurological manifestations are more commonly associated with severe COVID-19
infection. Guillain-Barré syndrome (GBS) is a rare immune-mediated
postinfectious neuropathy. It has been reported as a possible rare complication
of COVID-19. We report a case of GBS associated with COVID-19 in the UK.
Guillain-Barré syndrome following COVID-19: a newly emerging post-infectious complicationBMJ Case Reports - Tập 13 Số 6 - Trang e236182 - 2020
Silas Webb, Victoria C. J. Wallace, David Martín-López, Mahinda Yogarajah
A 57-year-old man presented with a progressive flaccid symmetrical motor and
sensory neuropathy following a 1-week history of cough and malaise. He was
diagnosed with Guillain-Barré syndrome secondary to COVID-19 and started on
intravenous immunoglobulin. He proceeded to have worsening respiratory function
and needed intubation and mechanical ventilation. This is the first reported
case of this ra... hiện toàn bộ
Guillain-Barré syndrome presenting with COVID-19 infectionBMJ Case Reports - Tập 13 Số 9 - Trang e236978 - 2020
Nasir Ameer, Kalyan Mansukhbhai Shekhda, Ann Cheesman
A construction worker in his 30s presented three times in 4 days with
progressive upper and then lower limb weakness. On the first two occasions he
had no systemic symptoms, but on the third presentation he had fever and cough,
starting from day 4 of weakness. Examination identified weakness in all four
limbs and areflexia, suggesting a peripheral neuromuscular disorder.
Investigations were consis... hiện toàn bộ
Paediatric case of prolonged COVID-19 manifesting as PMIS-TS and atypical KawasakiBMJ Case Reports - Tập 13 Số 9 - Trang e237194 - 2020
Mike Masih, Sarah Moll, Naila Raza
The COVID-19 pandemic has created an unprecedented disease burden worldwide,
affecting patients of all ages. Recently, there has been a rise in a new
inflammatory condition termed paediatric multisystem inflammatory syndrome
temporally associated with SARS-CoV-2 (PMIS-TS). We are yet to understand
significant risk factors, disease progression and prognosis in children
affected. We describe a case ... hiện toàn bộ
Severe thrombocytopaenia secondary to COVID-19BMJ Case Reports - Tập 13 Số 9 - Trang e237645 - 2020
Trupesh Patel, Noah J. Stanton, Ioannis Gkikas, Diana Triantafyllopoulou
The SARS-CoV-2 infection has caused a pandemic with a case rate of over 290 000
lab-confirmed cases and over 40 000 deaths in the UK. There is little evidence
to inform the optimal management of a patient presenting with new or relapsed
acute idiopathic thrombocytopaenic purpura with concurrent SARS-CoV-2 infection.
We present a case of severe thrombocytopaenia complicated by subdural haematoma
an... hiện toàn bộ
Guillain-Barré syndrome associated with COVID-19 diseaseBMJ Case Reports - Tập 13 Số 9 - Trang e237215 - 2020
Sindhuja Korem, Haresh Gandhi, Decerie B. Dayag
Clinical manifestations of COVID-19 are known to be variable with growing
evidence of nervous system involvement. In this case report, we describe the
symptoms of a patient infected with SARS-CoV-2 whose clinical course was
complicated with Guillain-Barré syndrome (GBS). We present a case of a
58-year-old woman who was initially diagnosed with COVID-19 pneumonia due to
symptoms of fever and cough.... hiện toàn bộ
Xuất huyết giảm tiểu cầu miễn dịch cấp tính ở một bệnh nhân COVID-19 và xơ gan không bù Dịch bởi AI BMJ Case Reports - Tập 13 Số 7 - Trang e236815 - 2020
Florent Artru, Lorenzo Alberio, Darius Moradpour, G. Stalder
Chúng tôi báo cáo một bệnh nhân mắc bệnh coronavirus 2019 (COVID-19) và xơ gan
không bù, người đã có kết quả khả quan với tình trạng xuất huyết giảm tiểu cầu
miễn dịch nặng (ITP) sau khi được điều trị bằng globulin miễn dịch tiêm tĩnh
mạch và dexamethasone liều cao. Trường hợp hiện tại cho thấy rằng việc xem xét
ITP là hợp lý trong trường hợp giảm tiểu cầu nghiêm trọng ở bệnh nhân COVID-19.